rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Craig A. Johnson

Director

Company insider

Files Form 4 as: Director, Aurinia Pharmaceuticals; Director, Heron Therapeutics; Director, Mirati Therapeutics; Director, La Jolla Pharmaceutical Co; Director, Odonate Therapeutics; Director, Adamis Pharmaceuticals; Director, Ardea Biosciences, Inc./DE; Sr. VP, CFO and Secretary, Novadel Pharma.

Every Form 4 they filed

In numbers

Trades disclosed
139
Buys
1
Sells
9
Bought
$51K
Sold
$5.7M
Companies
9
Companies where not an officer
7
First trade
3 Oct 2006
Last trade
4 Jun 2026
Last filed
8 Jun 2026

Companies traded

Where they are an officer
Novadel PharmaOfficer · last 16 Jun 20100 buys · 0 sells
TorreyPines TherapeuticsOfficer · last 3 Feb 20090 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AUPH Aurinia PharmaceuticalsDirector · Biotechnology · last 4 Jun 20260 buys · 0 sells
HRTX Heron TherapeuticsDirector · Biotechnology · last 30 Jan 20260 buys · 4 sells
Mirati TherapeuticsDirector · last 23 Jan 20240 buys · 3 sells
La Jolla Pharmaceutical CoDirector · last 22 Aug 20220 buys · 0 sells
Odonate TherapeuticsDirector · last 29 Dec 20201 buy · 0 sells
Adamis PharmaceuticalsDirector · last 16 Oct 20130 buys · 0 sells
Ardea Biosciences, Inc./DEDirector · last 19 Jun 20120 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Jun 2026filed 8 Jun 2026AUPH Aurinia Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—23,931 at $0.00filing
4 Jun 2026filed 8 Jun 2026AUPH Aurinia Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—23,931 at $0.00filing
30 Jan 2026filed 3 Feb 2026HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—53,960 at $0.00filing
30 Jan 2026filed 3 Feb 2026HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—53,960 at $0.00filing
21 Nov 2025filed 24 Nov 2025AUPH Aurinia PharmaceuticalsBiotechnologySEC FORM 4 Code F$95K6,039 at $15.68filing
16 May 2025filed 16 May 2025AUPH Aurinia Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—37,485 at $0.00filing
31 Jan 2025filed 4 Feb 2025HRTX Heron Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—35,900 at $0.00filing
31 Jan 2025filed 4 Feb 2025HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—17,950 at $0.00filing
30 Jan 2025filed 3 Feb 2025HRTX Heron Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$62K35,900 at $1.73filing
30 Jan 2025filed 3 Feb 2025HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—17,950 at $0.00filing
21 Nov 2024filed 25 Nov 2024AUPH Aurinia Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—31,688 at $0.00filing
21 Nov 2024filed 25 Nov 2024AUPH Aurinia PharmaceuticalsBiotechnologySEC FORM 4 Code A—20,631 at $0.00filing
23 Jan 2024filed 23 Jan 2024Mirati Therapeuticsoption or derivativeSEC FORM 4 Code D—10,000filing
23 Jan 2024filed 23 Jan 2024Mirati Therapeuticsoption or derivativeSEC FORM 4 Code D—18,000filing
23 Jan 2024filed 23 Jan 2024Mirati Therapeuticsoption or derivativeSEC FORM 4 Code D—10,000filing
23 Jan 2024filed 23 Jan 2024Mirati Therapeuticsoption or derivativeSEC FORM 4 Code D—7,520filing
23 Jan 2024filed 23 Jan 2024Mirati Therapeuticsoption or derivativeSEC FORM 4 Code D—11,000filing
23 Jan 2024filed 23 Jan 2024Mirati TherapeuticsSEC FORM 4 Code D—6,021filing
23 Jan 2024filed 23 Jan 2024Mirati TherapeuticsSEC FORM 4 Code D—4,444filing
23 Jan 2024filed 23 Jan 2024Mirati TherapeuticsSEC FORM 4 Code D—6,808filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4
Not placed6

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.